InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Watanabe Todd, See Remarks. Officer active across 1 company, notably Arcutis Biotherapeutics, Inc.. Aggregated, 9 reports have been logged. Split: 0 buy · 8 sells. Total volume traded: €2.2m. History available since 4 August 2025. The latest transaction was disclosed on 3 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Watanabe Todd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
4,375 shares@ US$26.1168Common StockSEC:0001628280-26-053753:0
102,000 shares0Common StockSEC:0001628280-26-014327:0
19,833 shares@ US$25.498420.4% of flowCommon StockSEC:0001628280-26-005570:0
1,055 shares@ US$30.001.7% of flowCommon StockSEC:0001801061-25-000012:0
11,478 shares@ US$24.712215.1% of flowCommon StockSEC:0001801061-25-000010:0
40,000 shares@ US$25.02580.032% mcap50.0% of flowCommon StockSEC:0001801061-25-000008:0
15,000 shares@ US$18.913517.4% of flowCommon StockSEC:0001801061-25-000006:0
9,625 shares@ US$17.537612.5% of flowCommon StockSEC:0001787306-25-000136:0
11,547 shares@ US$14.32667.7% of flowCommon StockSEC:0001787306-25-000119:0
9 of 9 declarations
About Watanabe Todd
Todd Watanabe is involved in various functions at Arcutis Biotherapeutics, Inc. His role includes specific responsibilities that contribute to the company's development and strategy. His expertise is an asset to the organization.
